EDAP vs. ZIMV, SMTI, TCMD, STIM, NVRO, TLSI, SGHT, BWAY, DRTS, and SKIN
Should you be buying EDAP TMS stock or one of its competitors? The main competitors of EDAP TMS include ZimVie (ZIMV), Sanara MedTech (SMTI), Tactile Systems Technology (TCMD), Neuronetics (STIM), Nevro (NVRO), TriSalus Life Sciences (TLSI), Sight Sciences (SGHT), Brainsway (BWAY), Alpha Tau Medical (DRTS), and Beauty Health (SKIN). These companies are all part of the "medical equipment" industry.
EDAP TMS vs. Its Competitors
ZimVie (NASDAQ:ZIMV) and EDAP TMS (NASDAQ:EDAP) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership and valuation.
EDAP TMS has lower revenue, but higher earnings than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than EDAP TMS, indicating that it is currently the more affordable of the two stocks.
ZimVie has a beta of 2.1, suggesting that its share price is 110% more volatile than the S&P 500. Comparatively, EDAP TMS has a beta of 0.02, suggesting that its share price is 98% less volatile than the S&P 500.
ZimVie presently has a consensus price target of $16.33, suggesting a potential upside of 73.57%. EDAP TMS has a consensus price target of $8.50, suggesting a potential upside of 408.98%. Given EDAP TMS's higher probable upside, analysts plainly believe EDAP TMS is more favorable than ZimVie.
ZimVie has a net margin of -4.40% compared to EDAP TMS's net margin of -34.45%. ZimVie's return on equity of 5.53% beat EDAP TMS's return on equity.
95.6% of ZimVie shares are owned by institutional investors. Comparatively, 62.7% of EDAP TMS shares are owned by institutional investors. 5.4% of ZimVie shares are owned by insiders. Comparatively, 0.2% of EDAP TMS shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
In the previous week, ZimVie and ZimVie both had 3 articles in the media. EDAP TMS's average media sentiment score of 0.94 beat ZimVie's score of 0.62 indicating that EDAP TMS is being referred to more favorably in the news media.
Summary
ZimVie beats EDAP TMS on 9 of the 16 factors compared between the two stocks.
Get EDAP TMS News Delivered to You Automatically
Sign up to receive the latest news and ratings for EDAP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EDAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
EDAP TMS Competitors List
Related Companies and Tools
This page (NASDAQ:EDAP) was last updated on 7/1/2025 by MarketBeat.com Staff